Merck and Eisai said on Friday a combination of their cancer therapies failed to extend the lives of patients with a type of ...

LONDON - ANGLE plc, a leading liquid biopsy company, has announced a significant development in cancer treatment strategy, ...

Adding a monoclonal antibody cocktail to the standard treatment for inoperable liver cancer nearly doubled the amount of time ...

Despite significant therapeutic advances, breast cancer remains a leading cause of cancer-related death in women. Treatment typically involves surgery and follow-up hormone therapy, but late effects ...

Johnson & Johnson beat Wall Street’s fourth-quarter expectations as strong cancer drug sales compensated for a decline in ...

A temporary freeze on meetings on the National Institutes of Health could lead to delays in disbursing research grants and in ...

This breakthrough represents a beacon of hope in the fight against pancreatic cancer and other hard-to-treat malignancies.

Cutting-edge targeted therapies are pushing back the line between life and death for cancer patients.However, these ...

Princess Kate recently shared the uplifting news of being in remission from cancer, bringing relief and joy to royal watchers ...

A medical startup claimed its blood filtering device could cure cancer. But multiple patients who used it died not long after.

Medicare spending on cancer drugs may not be associated with the drugs’ clinical benefits, such as overall survival or progression-free survival.

Johnson & Johnson, fresh off a $14.6 billion deal to buy neurological drugmaker Intra-Cellular, reported fourth-quarter sales ...